Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 83: 1492-1498, 1997;
8750-7587/97 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klokker, M.
Right arrow Articles by Pedersen, B. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klokker, M.
Right arrow Articles by Pedersen, B. K.

Vol. 83, Issue 5, 1492-1498, 1997

Adrenergic beta 1- and beta 1+2-receptor blockade suppress the natural killer cell response to head-up tilt in humans

M. Klokker, N. H. Secher, P. Madsen, M. Pedersen, and B. K. Pedersen

Departments of Infectious Diseases and Anesthesia, Copenhagen Muscle Research Center, Rigshospitalet, University of Copenhagen, DK-2200 Copenhagen N; and Danish Armed Forces Health Services, Jægersborg, DK-2820 Gentofte, Denmark

ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
ACKNOWLEDGEMENTS
FOOTNOTES
REFERENCES


ABSTRACT

Klokker, M., N. H. Secher, P. Madsen, M. Pedersen, and B. K. Pedersen. Adrenergic beta 1- and beta 1+2-receptor blockade suppress the natural killer cell response to head-up tilt in humans. J. Appl. Physiol. 83(5): 1492-1498, 1997.---To evaluate stress-induced changes in blood leukocytes with emphasis on the natural killer (NK) cells, eight male volunteers were followed during three trials of head-up tilt with adrenergic beta 1- (metoprolol) and beta 1+2- (propranolol) blockade and with saline (control) infusions. The beta 1- and beta 1+2-receptor blockade did not affect the appearance of presyncopal symptoms, but the head-up tilt induced a transient lymphocytosis that was abolished by beta 1+2-receptor blockade but not by beta 1-receptor blockade. Head-up tilt also resulted in delayed neutrophilia, which was insensitive to beta -receptor blockade. Lymphocyte subset analysis revealed that the head-up tilt resulted in a twofold increase in the percentage and absolute number of CD3-/CD16+ and CD3-/CD56+ NK cells in peripheral blood and that this increase was partially blocked by metoprolol and abolished by propranolol. The NK cell activity on a per NK cell basis did not change during head-up tilt, indicating that the cytotoxic capability of NK cells recruited to circulation is unchanged. The data suggest that the head-up tilt-induced lymphocytosis was due mainly to CD16+ and CD56+ NK cells and that their recruitment to the blood was inhibited by beta 1- and especially beta 1+2-receptor blockade. Thus stress-induced recruitment of lymphocytes, and of NK cells in particular, is mediated by epinephrine through activation of beta -receptors on the lymphocytes.

aviation medicine; catecholamines; gravity; leukocytes; lymphocytes; lymphocyte subsets; neutrophils; T cells


INTRODUCTION

THE IMMUNE SYSTEM is influenced by thermal and traumatic injury (4), surgery (26, 37), acute myocardial infarction (17), and even jet lag (18) and spaceflight (32, 35). Isolated physical stressors have been investigated in humans during exercise (30), hypoxia (19), hyperthermia (10, 12), head-up tilt (20), and various forms of stress that induce similar changes in the cellular immune system (8). The underlying mechanism is probably multifactorial and may be mediated in part by hormones (28).

This study focuses on the possible roles of adrenergic beta -receptors on lymphocytes in stress-induced immunomodulation. beta -Receptor blockade during exercise influences exercise performance. For the study of sympathoadrenergic blockade, we have, therefore, chosen a stress model that does not require active physical performance. Head-up tilt is an experimental model that is used to induce central hypovolemia as a model of "functional hemorrhage" in humans. Experiments with head-up tilt are reproducible, noninvasive, and acceptable for the volunteers. Also, head-up tilt can be considered to complement physical exercise in revealing mechanisms of importance regarding the influence of stress on the cellular immune system.

Natural killer (NK) cells are a heterogenous population of lymphocytes that mediate non-major-histocompatibility-restricted cytotoxicity. NK cells do not express CD3 (denoted CD3-), but the majority of human NK cell activity is mediated by the CD16+, CD56+, or CD16+/CD56+ cells (expressing CD16 and/or CD56 on cell surface) (27). Through multiple linear regression, it has been recently shown that it is especially the percentage of CD16+ cells that influences the NK cell activity in normal donors (39). We have previously described increased concentrations of lymphocytes and of NK cells in blood during head-up tilt (20). During the first phase of the head-up tilt (the normotensive phase), the concentrations of plasma norepinephrine, beta -endorphin, cortisol, and adrenocorticotropic hormone increase, whereas the plasma concentration of epinephrine increases at the onset of presyncopal symptoms (PS; nausea, dizziness, and a flushing sensation) with reduced heart rate and blood pressure (33). These hormones have immunomodulatory effects and could mediate the head-up tilt-related immune changes (20). Based on infusion studies showing that epinephrine mimics the effect of cycling on NK cells (16, 36), we hypothesized that adrenergic beta -receptor blockade would abolish the stress-induced recruitment of lymphocytes and especially of the NK cells to the blood. Therefore, we evaluated the influence of metoprolol (beta 1-receptor blockade) and propranolol (beta 1+2-receptor blockade) on immunocompetent cells during head-up tilt-provoked PS.


METHODS

Eight healthy men [age 26 (range 22-31) yr, weight 75 (67-85) kg, and height 179 (176-183) cm] volunteered as subjects after they gave informed consent to participate the study, which was approved by the Ethics Committee of Copenhagen (EC reference no. KF V 92210). The subjects were not specially trained for the purpose of head-up tilt and did not perform any regular sport activities. Subjects arrived in the laboratory at 8 AM, were postabsorptive for 10 h, and were allowed to drink only water. Infectious diseases within 10 days before the experiment or any history of cardiac and pulmonary disease excluded the subject.


Fig. 1. Effects of beta 1- and beta 1+2-blockade during head-up tilt compared with control on neutrophil (black-square) and lymphocyte (bullet ) concentrations. Blood samples were collected before, during head-up tilt at appearance of presyncopal symptoms (PS), 10 min after PS and return to supine position (PS+10), and 120 min after return to supine (PS+120). A: control head-up tilt. B: adrenergic beta 1-receptor blockade. C: adrenergic beta 1+2-receptor blockade. Values are means ± SE of 8 men. Statistically significant differences were determined by analysis of variance (ANOVA) and Tukey's honestly significant difference (HSD) post hoc test based on the ANOVA. * Significant difference between denoted value and preceding value, P <=  0.01. § Significant difference between value at PS during beta 1- or beta 1+2-blockade and value at PS in control trial, P <=  0.001.
[View Larger Version of this Image (12K GIF file)]


Fig. 2. Effects of beta 1- and beta 1+2-blockade during head-up tilt compared with control on CD3-/CD16+ (black-square) and CD3-/CD56+ (bullet ) natural killer (NK) cell concentrations. Values are means ± SE of 8 men. Statistically significant differences were determined by ANOVA and Tukey's HSD post hoc test based on the ANOVA. * Significant difference between denoted value and preceding value, P <=  0.001. § Significant difference between value at PS during beta 1- or beta 1+2-blockade and value at PS in control trial, P <=  0.001.
[View Larger Version of this Image (12K GIF file)]

Table  1.   Effects of beta 1- and beta 1+2-blockade during head-up tilt compared with control on percentage of CD3+ (pan T), CD4+ (T helper), CD8+ (T cytotoxic), CD14+ (monocytes), CD19+ (B lymphocytes), and CD16+ and CD56+ (NK) cells
Control
 beta 1-Blockade
 beta 1+2-Blockade
Before PS PS + 10  PS + 120  Before PS PS + 10  PS + 120  Before PS PS + 10  PS + 120 

CD3+ 71.7 ± 2.3  60.8 ± 3.2  70.0 ± 1.9  64.7 ± 3.0  72.5 ± 3.8  72.4 ± 3.1  77.2 ± 0.9  70.8 ± 2.1  72.8 ± 3.4  72.8 ± 3.1  73.0 ± 2.7  69.6 ± 2.7 
CD4+ 42.3 ± 1.5  37.2 ± 1.2  39.8 ± 2.7  37.4 ± 2.6  44.9 ± 2.2  35.2 ± 2.7* 45.8 ± 5.0  40.4 ± 3.9  41.5 ± 4.4  45.7 ± 1.8  45.6 ± 2.9  44.4 ± 3.1 
CD8+ 24.9 ± 3.9  30.0 ± 3.8  26.0 ± 4.8  24.5 ± 3.7  20.4 ± 3.1  26.0 ± 3.8  31.8 ± 6.0  22.8 ± 3.0  20.8 ± 3.7  26.9 ± 4.1  21.6 ± 3.0  24.2 ± 2.9 
CD14+ 14.9 ± 2.5  11.7 ± 1.7  13.9 ± 2.1  14.2 ± 2.3  13.9 ± 3.4  10.6 ± 1.8  8.3 ± 2.0  13.9 ± 3.1  14.1 ± 3.3  13.6 ± 2.3  12.2 ± 2.9  16.3 ± 3.6 
CD3-/   CD16+ 8.9 ± 1.5  20.2 ± 4.0* 7.7 ± 1.9  6.5 ± 2.0  3.0 ± 0.6  7.1 ± 1.6dagger 4.9 ± 0.8  6.3 ± 1.1  5.1 ± 2.1  5.2 ± 1.6dagger 4.0 ± 1.3  7.2 ± 2.4 
CD19+ 29.1 ± 9.0  14.7 ± 5.0  9.7 ± 4.0  20.4 ± 6.5  11.0 ± 3.3  14.2 ± 3.7  17.4 ± 3.9  21.6 ± 5.7  18.5 ± 5.2  14.7 ± 3.3  18.1 ± 5.6  15.3 ± 4.8 
CD3-/   CD56+ 9.5 ± 2.2  22.6 ± 4.6* 9.1 ± 2.0  7.8 ± 2.5  4.4 ± 1.3  10.1 ± 2.5dagger 4.9 ± 1.6  7.0 ± 2.2  7.5 ± 2.5  6.9 ± 2.0dagger 6.0 ± 2.1  8.6 ± 2.7

Values are means ± SE given in % of 8 men. A more precise estimation of natural killer (NK) cells was determined (CD3-/CD16+ and CD3-/CD56+ cells). Blood samples were collected before, during head-up tilt at appearance of presyncopal symptoms (PS), 10 min after PS and return to supine position (PS + 10), and 120 min after (PS + 120). Statistically significant differences were determined by analysis of variance (ANOVA) and Tukey's honestly significant difference (HSD) post hoc test based on the ANOVA. * Significant difference between value during head-up tilt at appearance of PS compared with initial and subsequent values, P <=  0.05.  dagger Significant difference between value at PS during beta 1- or beta 1+2-blockade and value at PS in control trial, P <=  0.05.


Fig. 3. Effects of beta 1- and beta 1+2-blockade during head-up tilt compared with control on NK cell activity (black-square, effector-target cell ratio = 100:1; bullet , effector-target cell ratio = 50:1). Values are means ± SE of 8 men. Statistically significant differences were determined by ANOVA and Tukey's HSD post hoc test based on the ANOVA. * Significant difference between beta -blockade during PS and preceding values, P <=  0.01. * Significant difference between beta -blockade and placebo pooled values during PS and preceding values, P <= 0.01 and P <=  0.05, respectively.
[View Larger Version of this Image (13K GIF file)]

Experiments were performed on a tilt table with a bicycle saddle and without support for the feet. After 30 min of supine rest, intravenous infusion of isotonic saline was started at 15 ml/h. After another 30 min of supine rest, head-up tilt to an angle of 50° was performed over 5 min (starting at time = 0 min), and the subject remained in this position until the onset of PS. With the occurrence of PS, the subject was immediately returned to the supine position (23). On other days, beta 1- and beta 1+2-receptor blockade were performed by intravenous infusion of metoprolol (1 mg/ml; Seloken, Astra Hässle, Albertslund, Denmark) or propranolol (1 mg/ml; Inderal, Zeneca, Copenhagen, Denmark), respectively. The infusion was started after 30 min of supine rest. The three trials were carried out in random order and separated by >2 wk.

A catheter (1.0 mm ID; 20 gauge) was inserted in the brachial artery of the nondominant arm for blood pressure and sampling of blood and was flushed with saline (3 ml/h). Arterial pressure was measured with a transducer (Bentley Laboratories, Uden, Holland) fastened to the subject at heart level in the midaxillary line and connected to a monitor (Simonsen & Weel, Copenhagen, Denmark). A venous catheter at the wrist was used for the administration of test or placebo substances. A bolus (0.13 mg/kg of metoprolol or propranolol) was injected over 3 min, and subsequently a constant dose (0.10 mg kg of metoprolol or propranolol) was administered by a pump (Injectomat 50, Fresenius Medicintechnik, Bad Humburg, Germany). A two-lead electrocardiogram was used to record heart rate. Arterial blood samples for immunological studies were drawn just before head-up tilt, at appearance of PS, after a further 10 min, and again after 120 min of recovery (4 × 60 ml).

Isolation of blood mononuclear cells. Fresh peripheral blood mononuclear cells (BMNC) were isolated by gradient centrifugation of heparinized blood on Lymphoprep (Nycomed, Oslo, Norway).

Determination of NK cell activity. The NK cell activity of BMNC was determined by using K562 target cells in a 51Cr-release assay (29). Triplicate cell cultures of 100 µl BMNC (10 × 106, 5 × 106, or 2.5 × 106 cells/ml), and 100 µl target cells (105 cells/ml) were incubated in microtiter plates for 3 h (effector-target cell ratio = 100:1, 50:1, or 25:1, respectively). The plates were centrifuged for 10 min, 100 µl of the supernatant were transferred to new tubes, and the radioactivity was determined. Spontaneous release was determined by incubation of 100 µl target cells with 100 µl medium. The maximum release was determined by incubation of 100 µl target cells plus 100 µl medium with a final concentration of 5% Triton X-100. The NK cell activity (51Cr release) was calculated as
Lysis = (test cpm − spontaneous cpm)/
(maximum cpm − spontaneous cpm)
where cpm is counts per minute and is reported as the mean of triplicate determinations. For subjects with NK cell activity (effector-target cell ratio = 100:1) >5%, lytic units (LU10) were calculated. One LU10 is the number of effector cells required to achieve 10% cytotoxicity of K562 as derived from a titration curve of twofold serial dilutions of effector cells. For LU10 >5% and positive correlation coefficient, lytic activities on a per cell basis were calculated as LU10 × 107 BMNC, LU10 × 107 CD3-/CD16+ cells and LU10 × 107 CD3-/CD56+ cells (39).

Cell-surface marker analysis by flow cytometry. BMNC subset concentrations were determined according to cell surface molecules by using monoclonal antibodies (CD markers). Lymphocytes were differentiated according to surface molecules: CD3 (pan T cells), CD4 (T helper cells), CD8 (T cytotoxic cells), CD14 (monocytes), CD19 (B lymphocytes), and CD16 and CD56 (NK cells). The fluorescein isothiocyanate (FITC)- and phycoerythrin (PE)-conjugated monoclonal antibodies anti-Leu2 (CD8), anti-Leu3 (CD4), anti-LeuM3 (CD14), anti-CD19 (CD19), anti-Leu4 (CD3), anti-Leu11 (CD16), and anti-CD56 (CD56) (Becton Dickinson, Mountain View, CA, and Dakopatts, Glostrup, Denmark) were used. The two latter were applied simultaneously with the use of anti-Leu4 (CD3) for determination of CD3-/CD16+ and CD3-/CD56+ NK cells. Cells were incubated with PE- (Becton Dickinson) and FITC-conjugated (Dakopatts) mouse immunoglobulin G1 and G2, which were used as negative controls. The BMNC (1 × 106) were washed twice in phosphate-buffered saline (PBS) with 2% fetal calf serum (FCS) and resuspended in 100 µl PBS containing 2% FCS and 10 µl of the monoclonal antibody. After incubation on ice for 45 min, the cells were washed twice in a balanced electrolyte solution. Labeled cells were analyzed by flow cytometry by using a fluorescent-activated cell sorter (Becton Dickinson).

Cell concentrations. Lymphocyte and neutrophil concentrations were determined by using a cell counter (model H.1, Technicon).

Statistics. Analysis of variance (ANOVA) was used to evaluate changes with time and trials (model: dependent variable = constant + subject + trial + time + trial × time; Systat, Evanston, IL). If proven significant (P <=  0.05), Tukey's honestly significant difference (HSD) post hoc test based on ANOVA categorical variables trial and time and interaction product trial × time were performed. Logarithmic transformation of LU10 data was performed to allow ANOVA calculation. P <=  0.05 was considered statistically significant. The calculated probability values referred to in text and Figs. 1, 2, 3 are true for both the ANOVA and Tukey's HSD tests. The data in Figs. 1, 2, 3 and Tables 1 and 2 are given as means ± SE. Initial power calculations revealed that to detect changes in NK cell activity of >10% activity [delta  = 0.10; type I error, alpha  = 0.05; type II error, beta  = 0.20 right-arrow power = 80%. Based on previous studies (20) estimated SD = ~10% right-arrow standardized difference (2delta /SD) = 2.0], the sample size was found to be approximately eight subjects in three groups of continuous data in the ANOVA. Justifications for this sample size include the fact that the subject group was homogenous and that the test persons served as their own controls.

Table  2.   Effects of beta 1- and beta 1+2-blockade during head-up tilt compared with control on NK cell cytotoxicity
Control
 beta 1-Blockade
 beta 1+2-Blockade
Before PS PS + 10  PS + 120  Before PS PS + 10  PS + 120  Before PS PS + 10  PS + 120 

LU10 × 107 BMNC 0.80 ± 0.53  1.26 ± 0.29  1.08 ± 0.55  0.28 0.11  0.38 ± 0.10  1.79 ± 1.07  1.07 ± 0.52  0.58 ± 0.24  0.24 ± 0.10  0.59 ± 0.28  0.23 ± 0.13  0.43 ± 0.15 
  P (ANOVA, trial) 0.755 0.006*
  P (ANOVA, time) 0.218 0.093
LU10 × 107 CD3-/CD16+ 9.69 ± 5.65  7.21 ± 1.77  17.70 ± 7.49  8.18 ± 4.76  12.75 ± 2.86  21.37 ± 11.75  32.38 ± 19.77  10.05 ± 4.96  6.38 ± 2.48  12.08 ± 2.08  9.25 ± 2.27  5.21 ±2.28
  P (ANOVA, trial) 0.861 0.962
  P (ANOVA, time) 0.744 0.201
LU10 × 107 CD3-/CD56+ 10.25 ± 4.93  7.18 ± 2.02  16.42 ± 8.45  6.83 ± 5.25  6.82 ± 3.62  16.35 ± 8.73  58.43 ± 42.53  7.43 ± 1.97  3.75 ± 1.66  11.38 ± 3.34  5.27 ±1.43 3.35 ± 1.20 
  P (ANOVA, trial) 0.374 0.762
  P (ANOVA, time) 0.450 0.303

Values are means ± SE of 8 men. Lytic units (LU10) on per cell basis were calculated as LU10 × 107 blood mononuclear cells (BMNC), LU10 × 107 CD3-/CD16+ and LU10 × 107 CD3-/CD56+ NK cells. Blood samples were collected before and at PS, PS + 10, and PS + 120. P (ANOVA, time) and P (ANOVA, trial), probability connected with estimated main effect time and trial, respectively. * Probability of statistical significant difference in ANOVA. No Tukey's HSD post hoc test was significant.


RESULTS

During control head-up tilt, PS appeared after 21.6 ± 3.1 (SE) min and after 20.6 ± 5.4 and 16.3 ± 4.9 min with beta 1- and beta 1+2-receptor blockade, respectively, with no significant differences between trials. Infusions with metoprolol and propranolol were not associated with any side effects. The beta 1- and beta 1+2-receptor blockade did not affect the bradycardic-hypotensive reaction to head-up tilt (mean arterial pressure = 55 ± 4 and 51 ± 4 mmHg, respectively, compared with 49 ± 3 mmHg in the control head-up tilt). The only cardiovascular finding was an abolished head-up tilt-induced increase in heart rate to 57 ± 2 and 55 ± 3 beats/min during beta 1- and beta 1+2-receptor blockade, respectively, compared with 66 ± 4 beats/min in the control trial.

No significant differences were found between pre-head-up tilt values of dependent variables of any trial. Except for beta 1+2-receptor blockade, the lymphocyte concentration increased during head-up tilt and returned to the pre-head-up tilt value 10 min after PS (P < 0.01). During head-up tilt with beta 1+2-receptor blockade, no changes in lymphocyte concentration could be demonstrated, and this was in contrast to the lymphocyte concentration at the appearance of PS in the control trial (P < 0.001; Fig. 1). The neutrophils increased during head-up tilt (P < 0.01) and increased further after 120 min of recovery (P < 0.001), and this was not influenced by beta 1- or beta 1+2-receptor blockade.

The concentration and percentage of CD3-/CD16+ and CD3-/CD56+ NK cells increased during head-up tilt (P < 0.01), but the recruitment of NK cells to the blood was reduced during beta 1-receptor blockade and completely abolished by beta 1+2-receptor blockade (P < 0.01 compared with control; Fig. 2, Table 1). Head-up tilt had only a minor influence on other BMNC subpopulations, and beta -receptor blockade did not influence the changes in these subpopulations. The NK cell activity increased during head-up tilt (P < 0.05), and this increase tended to be less pronounced during beta 1- or beta 1+2-receptor blockade, but there was no significant difference (effector-target cell ratios = 50:1 and 100:1 are shown in Fig. 3; effector-target cell ratio = 25:1 is not shown). The cytotoxicity on a per cell basis, LU10 × 107 BMNC, was borderline significantly elevated during PS in all trials (P = 0.093), whereas in beta 1+2-receptor blockade all observations not distinguishing between the time were reduced compared with the control (P < 0.01). No changes in LU10 × 107 CD3-/CD56+ or LU10 × 107 CD3-/CD56+ NK cells were found (Table 2).

The hemoglobin concentrations were 8.8 ± 0.1, 8.9 ± 0.1, and 8.9 ± 0.1 × 10-3 mol/l before and 9.3 ± 0.2, 9.4 ± 0.1, and 9.3 ± 0.1 × 10-3 mol/l during head-up tilt in the placebo and beta 1- and beta 1+2-receptor blockade trials, respectively, with no significant differences between the trials.


DISCUSSION

This study confirmed that head-up tilt induces neutrocytosis and lymphocytosis (20). The increased lymphocyte concentration was due mainly to recruitment of NK cells to the blood, and, accordingly, the NK cell activity (lysis per fixed number of BMNC) increased during head-up tilt. The study demonstrates that adrenergic beta -receptor blockade inhibits the head-up tilt-induced lymphocytosis and abolishes the increase in number and percentage of NK cells. Also, it may partly block the NK cell activity.

beta 1+2-Receptor blockade with propranolol inhibits exercise-induced lymphocytosis (2). In numerous species, the expression of adrenergic beta -receptors on T, B, and NK cells provides the molecular basis for these cells to be targets for catecholamine signaling (21). beta -Receptors on lymphocytes are linked intracellularly to the adenyl cyclase system (5), and the beta -receptor density changes in concert with lymphocyte activation and differentiation (1). Dynamic exercise upregulates the adrenergic beta -receptor density, especially on NK cells (22). In humans, a single epinephrine injection induces a transient increase in the number of circulating blood lymphocytes and monocytes (36) and reduces the response to T-cell mitogens (6). The finding that epinephrine infusion is capable of mimicking the effect of cycling, especially with respect to recruitment of cells mediating NK and lymphokine-activated killer cell activity (13, 36, 38) is compatible with the finding that exercise induces upregulation of adrenergic beta -receptors on NK cells but not on other lymphocyte subsets (22). There is evidence that the sympathetic nervous system may be involved in the control of cellular immunity in the spleen (14, 21). The murine splenic NK cell activity is enhanced by splenic denervation (31) and is suppressed by exposure to norepinephrine or an agonist (7). Furthermore, electrical stimulation of splenic nerve results in suppression of the splenic NK cell activity, which was blocked by injection of a peripherally acting adrenergic beta -receptor blocking agent (15). The finding of an effect of adrenergic beta -blockade on the NK cells in the peripheral blood in humans corresponds to the finding on murine splenic NK cells. This may reflect the fact that during stress NK cells are partly recruited to the peripheral blood from the spleen. However, infusion of epinephrine (34) and exercise (9) do cause lymphocytosis, and based on these studies the spleen plays only a minor role in stress-induced lymphocytosis. However, another recent study in splenectomized subjects suggests that the spleen accounts for one-third of the lymphocytosis in exercise (25). Other possible sites from which cell mobilization may occur include the lymphoid organs and the bone marrow.

The present study showed that the heart rate decreased during both beta 1- and beta 1+2-adrenergic blockade. Although heart rate and associated hemodynamic changes may directly influence the number of NK cells that are recruited to the blood, this is not likely to be the most important mechanism of action, especially because beta 1+2-adrenergic blockade inhibited the mobilization of NK cells. However, the finding that beta 2-receptor agonists, but not beta 1-agonists, induce selective detachment of NK cells from endothelial cells (3) and that beta 1+2 more than beta 1-receptor antagonists inhibited the mobilization of NK cells to the blood, lends support to the hypothesis that catecholamines, via beta 2-adrenergic receptors, can induce recruitment of NK cells from the marginating to the circulating pool, by changing the adhesive interactions between NK cells and endothelial cells. The finding that adrenergic beta -receptor blockade did not significantly inhibit the increase in NK cell activity may be due to an insufficient number of volunteers and large interindividual variation, because there was a tendency toward a lower increase in NK cell activity during beta 1+2- receptor blockade (Table 2, Fig. 3). The NK cell activity on a per cell basis did not change significantly during and after head-up tilt. This indicates that the cytotoxic capability of the NK cells recruited to the circulation is unchanged. beta 1+2-Receptor blockade had an inhibiting effect on the NK cell activity on a per cell basis, indicating that beta 1+2-receptor blockade did not just inhibit the recruitment of NK cells to circulation but inhibited the function of the individual cell. This may be mediated through the adenyl cyclase system (5).

beta -Receptor blockade did not abolish the head-up-tilt-induced neutrocytosis, which is in accordance with the finding that infusion of epinephrine does not induce neutrocytosis to the same extent as does exercise (3). However, during exercise, growth hormone and cortisol are known to cause marked neutrocytosis (11, 24), and our hypothesis is that epinephrine and cortisol, but in head-up tilt probably not growth hormone (unpublished observations), mediate the acute stress effect on neutrophils (8), and, therefore, beta -receptor blockade did not inhibit head-up tilt-related neutrocytosis.

Although no cardiovascular changes occurred during adrenergic beta 1- and beta 1+2-receptor blockade except for an abolished head-up tilt-induced increase in heart rate, they did suppress the stress response of NK cells. The present study and most other studies focusing on mechanisms of NK activation during stress (28) are limited to young healthy men, and there is an absence of data on other population segments (women and middle-aged and elderly individuals). However, the available results indicate that the epinephrine mediates the recruitment of NK cells from the marginating pool in blood vessels during stress through activation of beta -receptors on BMNC.


ACKNOWLEDGEMENTS

The excellent technical assistance of Ruth Rousing, Hanne Villumsen, Elise Møller, Lars Brogaard, and Anne Asanovski is acknowledged. Anders F. Johnsen and Viggo Lemche, the Danish Defence Research Establishment, and Henrik Ullum are thanked for valuable statistical discussions.


FOOTNOTES

   This work was supported by grants from the Danish Armed Forces Health Services; the Danish Hospital Foundation for Medical Research Region Copenhagen, the Faroe Islands, and Greenland; and the Danish National Research Foundation (504-14).

Address for reprint requests: M. Klokker, Dept. of Infectious Diseases, M 7641, Rigshospitalet, Tagensvej 20, DK-2200 Copenhagen N, Denmark (E-mail: Klokker{at}dk-online.dk).

Received 22 May 1996; accepted in final form 26 June 1997.


REFERENCES

1. Ackerman, K. D., D. L. Bellinger, S. Y. Felten, and D. L. Felten. Ontogeny and senescence of noradrenergic innervation of the rodent and spleen. In: Psychoneuroimmunology, edited by R. Ader, D. L. Felten, and N. Cohen. San Diego, CA: Academic, 1991, p. 71-125.
2. Ahlborg, B., and G. Ahlborg. Exercise leukocytosis with and without beta-adrenergic blockade. Acta Med. Scand. 187: 241-246, 1970[Medline].
3. Benschop, R. J., F. P. Nijkamp, R. E. Ballieux, and C. J. Heijnen. The effects of beta-adrenoceptor stimulation on adhesion of human natural killer cells to cultured endothelium. Br. J. Pharmacol. 113: 1311-1316, 1994[Medline].
4. Blazar, B. A., M. L. Rodrick, J. B. O'Mahony, J. Wood, P. Q. Bessey, D. W. Wilmore, and J. A. Mannick. Suppression of natural killer cell function in humans following thermal and traumatic injury. J. Clin. Immunol. 6: 26-36, 1986[Medline].
5. Carlson, S. L., W. H. Brooks, and T. L. Roszman. Neurotransmitter-lymphocyte interactions: dual receptor modulation of lymphocyte proliferation and cAMP production. J. Neuroimmunol. 24: 155-162, 1989[Medline].
6. Crary, B., M. Borysenko, D. C. Sutherland, I. Kutz, J. Z. Borysenko, and H. Benson. Decrease in mitogen responsiveness of mononuclear cells from peripheral blood after epinephrine administration in humans. J. Immunol. 130: 694-697, 1983[Abstract].
7. Hellstrand, K., S. Hermodsson, and Ö. Strannegård. Evidence for a beta-adrenoceptor-mediated regulation of human natural killer cells. J. Immunol. 134: 4095-4099, 1985[Abstract].
8. Hoffman-Goetz, L., and B. K. Pedersen. Exercise and the immune system: a model of the stress response? Immunol. Today 15: 382-387, 1994[Medline].
9. Iversen, P. O., B. L. Arvesen, and H. B. Benestad. No mandatory role for the spleen in the exercise-induced leucocytosis in man. Clin. Sci. (Colch.) 86: 505-510, 1994[Medline].
10. Kappel, M., M. Diamant, M. B. Hansen, M. Klokker, and B. K. Pedersen. Effects of in vitro hyperthermia on the proliferative response of blood mononuclear cell subsets, and detection of interleukins 1 and 6, tumour necrosis factor-alpha and interferon-gamma. Immunology 73: 304-308, 1991[Medline].
11. Kappel, M., M. B. Hansen, M. Diamant, J. O. Jørgensen, A. Gyhrs, and B. K. Pedersen. Effects of an acute bolus growth hormone infusion on the human immune system. Horm. Metab. Res. 25: 579-585, 1993[Medline].
12. Kappel, M., C. Stadeager, N. Tvede, H. Galbo, and B. K. Pedersen. Effects of in vivo hyperthermia on natural killer cell activity, in vitro proliferative responses and blood mononuclear cell subpopulations. Clin. Exp. Immunol. 84: 175-180, 1991[Medline].
13. Kappel, M., N. Tvede, H. Galbo, P. M. Haahr, M. Kjær, M. Linstow, K. Klarlund, and B. K. Pedersen. Evidence that the effect of physical exercise on NK cell activity is mediated by epinephrine. J. Appl. Physiol. 70: 2530-2534, 1991[Abstract/Free Full Text].
14. Katafuchi, T., T. Ichijo, S. Take, and T. Hori. Hypothalamic modulation of splenic natural killer cell activity in rats. J. Physiol. (Lond.) 471: 209-221, 1993[Abstract/Free Full Text].
15. Katafuchi, T., S. Take, and T. Hori. Roles of sympathetic nervous system in the suppression of cytotoxicity of splenic natural killer cells in the rat. J. Physiol. (Lond.) 465: 343-357, 1993[Abstract/Free Full Text].
16. Kay, N., J. Allen, and J. E. Morley. Endorphins stimulate normal human peripheral blood lymphocyte natural killer activity. Life Sci. 35: 53-59, 1984[Medline].
17. Klarlund, K., B. K. Pedersen, T. G. Theander, and V. Andersen. Depressed natural killer cell activity in acute myocardial infarction. Clin. Exp. Immunol. 70: 209-216, 1987[Medline].
18. Klokker, M., H. Galbo, I. Bygbjerg, and B. K. Pedersen. Minor effects of long distance flight on cellular immune system in female flight attendants. Int. Rev. Armed Forces Med. Ser. 67: 325-329, 1994.
19. Klokker, M., A. Kharazmi, H. Galbo, I. Bygbjerg, and B. K. Pedersen. Influence of in vivo hypobaric hypoxia on function of lymphocytes, neutrocytes, natural killer cells, and cytokines. J. Appl. Physiol. 74: 1100-1106, 1993[Abstract/Free Full Text].
20. Klokker, M., N. H. Secher, S. Matzen, and B. K. Pedersen. Natural killer cell activity during head-up tilt-induced central hypovolemia in humans. Aviat. Space Environ. Med. 64: 1128-1132, 1993[Medline].
21. Madden, K. S., and D. L. Felten. Experimental basis for neural-immune interactions. Physiol. Rev. 75: 77-106, 1995[Free Full Text].
22. Maisel, A. S., T. Harris, C. A. Rearden, and M. C. Michel. beta -Adrenergic receptors in lymphocyte subsets after exercise---alterations in normal individuals and patients with congestive heart failure. Circulation 82: 2003-2010, 1990[Abstract/Free Full Text].
23. Matzen, S., U. Knigge, H. J. Schutten, J. Warberg, and N. H. Secher. Atrial natriuretic peptide during head-up tilt induced hypovolaemic shock in man. Acta Physiol. Scand. 140: 161-166, 1990[Medline].
24. McCarthy, D. A., and M. M. Dale. The leukocytosis of exercise. A review and model. Sports Med. 6: 333-363, 1988[Medline].
25. Nielsen, H. B., N. H. Secher, J. Halkjær-Kristensen, N. J. Christensen, K. Espersen, and B. K. Pedersen. Splenectomy impairs lymphocytosis during maximal exercise (Abstract). Med. Sci. Sports Exerc. 28: S92, 1996.
26. Nielsen, H. J., B. K. Pedersen, F. Moesgaard, P. M. Haahr, and H. Kehlet. Effect of ranitidine on postoperative suppression of natural killer cell activity and delayed hypersensitivity. Acta Chir. Scand. 155: 377-382, 1989[Medline].
27. O'Shea, J., and J. R. Ortaldo. The biology of natural killer cells: insights into the molecular basis of function. In: The Natural Immune System---The Natural Killer Cell, edited by C. E. Lewis, and J. O. McGee. Oxford, UK: Oxford Univ. Press, 1992, p. 1-40.
28. Pedersen, B. K., M. Kappel, M. Klokker, H. B. Nielsen, and N. H. Secher. The immune system during exposure to extreme physiologic conditions. Int. J. Sports Med. 15, Suppl. 3: S116-S121, 1994.
29. Pedersen, B. K., and A. Kharazmi. Inhibition of human natural killer cell activity by Pseudomonas aeruginosa alkaline protease and elastase. Infect. Immun. 55: 986-989, 1987[Abstract/Free Full Text].
30. Pedersen, B. K., and H. Ullum. NK cell response to physical activity: possible mechanisms of action. Med. Sci. Sports Exerc. 26: 140-146, 1994[Medline].
31. Reder, A., M. Checinski, and E. Chelmicka Schorr. The effect of chemical sympathectomy on natural killer cells in mice. Brain Behav. Immun. 3: 110-118, 1989[Medline].
32. Rykova, M. P., G. Sonnenfeld, A. T. Lesnyak, G. R. Taylor, D. O. Meshkov, A. D. Mandel, A. E. Medvedev, W. D. Berry, B. B. Fuchs, and I. V. Konstantinova. Effect of spaceflight on natural killer cell activity. J. Appl. Physiol. 73, Suppl.: 196S-200S, 1992.
33. Secher, N. H., J. Jacobsen, D. B. Friedman, and S. Matzen. Bradycardia during reversible hypovolaemic shock: associated neural reflex mechanisms and clinical implications. Clin. Exp. Pharmacol. Physiol. 19: 733-743, 1992[Medline].
34. Steel, C. M., E. B. French, and W. R. Aitchison. Studies on adrenaline-induced leucocytosis in normal man. I. The role of the spleen and of the thoracic duct. Br. J. Haematol. 21: 413-421, 1971[Medline].
35. Taylor, G. R., and J. R. Dardano. Human cellular immune responsiveness following space flight. Aviat. Space Environ. Med. 54, Suppl. 12: S55-S59, 1983.
36. Tønnesen, E., N. J. Christensen, and M. M. Brinkløv. Natural killer cell activity during cortisol and adrenaline infusion in healthy volunteers. Eur. J. Clin. Invest. 10: 497-503, 1987.
37. Tønnesen, E., N. Hüttel, N. J. Christensen, and O. Schmitz. Natural killer cell activity in patients undergoing upper abdominal surgery: relationship to the endocrine stress response. Acta Anaesthesiol. Scand. 28: 654-660, 1984[Medline].
38. Tvede, N., M. Kappel, K. Klarlund, S. Duhn, J. Halkjær-Kristensen, M. Kjær, H. Galbo, and B. K. Pedersen. Evidence that the effect of bicycle exercise on blood mononuclear cell proliferative responses and subsets is mediated by epinephrine. Int. J. Sports Med. 15: 100-104, 1994[Medline].
39. Ullum, H., P. C. Götzsche, J. Victor, E. Dickmeiss, P. Skinhøj, and B. K. Pedersen. Defective natural immunity: an early manifestation of human immunodeficiency virus infection. J. Exp. Med. 182: 789-799, 1995[Abstract/Free Full Text].

0161-7567/97 $5.00 Copyright © 1997 the American Physiological Society



This article has been cited by other articles:


Home page
Evid Based Complement Alternat MedHome page
K. Takeda and K. Okumura
CAM and NK Cells
Evid. Based Complement. Altern. Med., June 1, 2004; 1(1): 17 - 27.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
R. L. Starkie, J. Rolland, and M. A. Febbraio
Effect of adrenergic blockade on lymphocyte cytokine production at rest and during exercise
Am J Physiol Cell Physiol, October 1, 2001; 281(4): C1233 - C1240.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. Steensberg, A. D. Toft, P. Schjerling, J. Halkjar-Kristensen, and B. K. Pedersen
Plasma interleukin-6 during strenuous exercise: role of epinephrine
Am J Physiol Cell Physiol, September 1, 2001; 281(3): C1001 - C1004.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
B. K. Pedersen and L. Hoffman-Goetz
Exercise and the Immune System: Regulation, Integration, and Adaptation
Physiol Rev, July 1, 2000; 80(3): 1055 - 1081.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klokker, M.
Right arrow Articles by Pedersen, B. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klokker, M.
Right arrow Articles by Pedersen, B. K.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online